Does DAPAGLIFLOZIN Cause Muscular weakness? 389 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 389 reports of Muscular weakness have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 1.8% of all adverse event reports for DAPAGLIFLOZIN.
389
Reports of Muscular weakness with DAPAGLIFLOZIN
1.8%
of all DAPAGLIFLOZIN reports
0
Deaths
114
Hospitalizations
How Dangerous Is Muscular weakness From DAPAGLIFLOZIN?
Of the 389 reports, 114 (29.3%) required hospitalization, and 101 (26.0%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 389 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which DAPAGLIFLOZIN Alternatives Have Lower Muscular weakness Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN